Skip to main content

Table 1 Baseline and 0–6-month change characteristics for n = 242 participants with complete data during 0–6 months

From: Is glycaemic control associated with dietary patterns independent of weight change in people newly diagnosed with type 2 diabetes? Prospective analysis of the Early-ACTivity-In-Diabetes trial

  

0–6 m participant characteristics (models 1a-3)

n (% full cohort)

 

242 (41%)

Arm, n (% sample)

  
 

Usual care

16 (7%)

 

Diet

115 (48%)

 

Diet and exercise

111 (46%)

Male, n (%)

 

163 (67%)

White ethnicity, n (%)

 

236 (98%)

Smoker at baseline, n (%)

 

17 (7%)

Age, years

 

62 (57, 69)

Time since diagnosis, years

 

0.5 (0.4, 0.6)

IMD score

 

12.6 (6.4, 18.9)

Total activity, counts/min

 

291 (226, 363)

Total activity change 0–6 m, counts/min

 

16 (− 44, 91)

MVPA, mins/day

 

21 (13, 36)

MVPA change 0–6 m, mins/day

 

3 (− 6, 18)

Weight, kg

 

86.5 (77.1, 94.0)

Weight change 0–6 m, kg

 

− 2.1 (− 3.9, − 0.1)

BMI, kg/m2

 

29.5 (27.3, 32.7)

BMI change 0–6 m, kg/m2

 

− 0.7 (− 1.4, 0.0)

HbA1c, mmol/mol

 

47 (43, 54)

HbA1c, %

 

6.5 (6.1, 7.1)

HbA1c change 0–6 m, mmol/mol

 

− 2.2 (− 5.5, 3.3)

HbA1c change 0–6 m, %

 

− 0.2 (− 0.5, 0.3)

OHA prescription, n (%)

  
 

Metformin

85 (35%)

 

Sulphonylurea

22 (9%)

 

Glitazone

2 (1%)

Baseline under-reporters, n (%)

 

142 (56%)

  1. Data presented as median (quartile 1, quartile 3) or n (%). IMD index of multiple deprivation, MVPA moderate-vigorous physical activity, OHA oral-hypoglycaemic agent